Receptor-binding domain as a target for developing SARS vaccines

作者: Lanying Du , Shibo Jiang , Shibo Jiang , Xiaojie Zhu , Lu Lu

DOI: 10.3978/J.ISSN.2072-1439.2013.06.06

关键词:

摘要: A decade ago, severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) caused a global pandemic with mortality rate of 10%. Reports recent outbreaks SARS-like disease by Middle East (MERS-CoV) have raised serious concerns possible reemergence SARS-CoV, either laboratory escape or the presence natural reservoir. Therefore, development effective and safe SARS vaccines is still needed. Based on our previous studies, we believe that receptor-binding domain (RBD) in S1 subunit SARS-CoV spike (S) protein most important target for developing vaccine. In particular, RBD S contains critical neutralizing (CND), which able to induce highly potent antibody response cross-protection against divergent strains. Furthermore, RBD-based vaccine expected be safer than other may Th2-type immunopathology. This review will discuss key advances possibility using similar strategy develop MERS-CoV.

参考文章(42)
M. Daeron, F. Kien, I. Dutry, J. S.M. Peiris, R. Bruzzone, Martial Jaume, A. Roberts, Y. W. Kam, N. Escriou, B. Nal, K. Subbarao, P. H. Li, M. S. Yip, R. Altmeyer, C. Y. Cheung, SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement. Hong Kong Medical Journal. ,vol. 18, pp. 31- 36 ,(2012)
Lanying Du, Guangyu Zhao, Yongping Lin, Hongyan Sui, Chris Chan, Selene Ma, Yuxian He, Shibo Jiang, Changyou Wu, Kwok-Yung Yuen, Dong-Yan Jin, Yusen Zhou, Bo-Jian Zheng, Intranasal Vaccination of Recombinant Adeno-Associated Virus Encoding Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Spike Protein Induces Strong Mucosal Immune Responses and Provides Long-Term Protection against SARS-CoV Infection Journal of Immunology. ,vol. 180, pp. 948- 956 ,(2008) , 10.4049/JIMMUNOL.180.2.948
Wenhui Li, Michael J. Moore, Natalya Vasilieva, Jianhua Sui, Swee Kee Wong, Michael A. Berne, Mohan Somasundaran, John L. Sullivan, Katherine Luzuriaga, Thomas C. Greenough, Hyeryun Choe, Michael Farzan, Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. ,vol. 426, pp. 450- 454 ,(2003) , 10.1038/NATURE02145
Fang Li, Wenhui Li, Michael Farzan, Stephen C Harrison, Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor Science. ,vol. 309, pp. 1864- 1868 ,(2005) , 10.1126/SCIENCE.1116480
Hongliang Wang, Peng Yang, Kangtai Liu, Feng Guo, Yanli Zhang, Gongyi Zhang, Chengyu Jiang, SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway Cell Research. ,vol. 18, pp. 290- 301 ,(2008) , 10.1038/CR.2008.15
M. Bolles, D. Deming, K. Long, S. Agnihothram, A. Whitmore, M. Ferris, W. Funkhouser, L. Gralinski, A. Totura, M. Heise, R. S. Baric, A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge Journal of Virology. ,vol. 85, pp. 12201- 12215 ,(2011) , 10.1128/JVI.06048-11
Yuxian He, Qingyu Zhu, Shuwen Liu, Yusen Zhou, Baoan Yang, Jiaming Li, Shibo Jiang, Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines Virology. ,vol. 334, pp. 74- 82 ,(2005) , 10.1016/J.VIROL.2005.01.034
G. Simmons, D. N. Gosalia, A. J. Rennekamp, J. D. Reeves, S. L. Diamond, P. Bates, Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry Proceedings of the National Academy of Sciences of the United States of America. ,vol. 102, pp. 11876- 11881 ,(2005) , 10.1073/PNAS.0505577102
Declan Butler, SARS veterans tackle coronavirus Nature. ,vol. 490, pp. 20- 20 ,(2012) , 10.1038/490020A